Published in Nature · View the paper (DOI)
Researchers have developed next-generation influenza vaccines that protect against a wide variety of seasonal and pandemic strains, including avian viruses H5N1 and H7N9. These nanoparticle-based vaccines spur strong immune responses in animal trials, potentially lowering the risk of bad flu seasons.
Coverage from 2 institutions
- Nanoparticle flu vaccine blocks seasonal and pandemic strains University of Washington School of Medicine/UW Medicine · Mar 24, 2021 · first to report
- NIH launches clinical trial of universal influenza vaccine candidate NIH/National Institute of Allergy and Infectious Diseases · Jun 1, 2021